• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The burden of chronic kidney disease (CKD) and its risk factors are projected to rise in
parallel with the rapidly ageing global population. By 2050, the prevalence of CKD category …

Background Effective targets for systolic blood-pressure control in patients with type 2
diabetes are unclear. Methods We enrolled patients 50 years of age or older with type 2 …

Background Uncertainty exists about whether lowering systolic blood pressure to less than
120 mm Hg is superior to that of less than 140 mm Hg, particularly in patients with diabetes …

The European Society of Hypertension (ESH) reported in 2023 its current Guidelines for the
management of arterial hypertension [1]. Following their aim to summarize the best available …

Objective To analyze the gut microbiota of patients with rheumatoid arthritis (RA) according
to disease activity. Methods An observational cross-sectional study of 110 patients with RA …

Background In an effort to improve migraine management around the world, the
International Headache Society (IHS) has here developed a list of practical …

Chronic kidney disease (CKD) affects over 850 million people globally, and there is an
urgent need to prevent its development and progression. During the last decade, new …

The spectrum of cardiorenal and metabolic diseases comprises many disorders, including
obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular …

J Clin Hypertens (Greenwich). 2012; 14: 429–434.© 2012 Wiley Periodicals, Inc. The aim of
this study was to validate a French translation of the structured self‐report 8‐item Morisky …